New patent for Adamis Pharms drug SYMJEPI

June 18, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for SYMJEPI Symjepi is a drug marketed by Adamis Pharms Corp and is included in one NDA. SYMJEPI drug price trends. The generic ingredient in SYMJEPI…

The post New patent for Adamis Pharms drug SYMJEPI appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.